These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3213262)

  • 1. [Determination of endotoxin in inflammatory rheumatic diseases--the effect of nonsteroidal anti-inflammatory agents on intestinal permeability].
    Busch J; Hammer M; Brunkhorst R; Wagener P
    Z Rheumatol; 1988; 47(3):156-60. PubMed ID: 3213262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Non-steroidal anti-inflammatory agents increase intestinal permeability].
    Auer IO; Habscheid W; Hiller S; Gerhards W; Eilles C
    Dtsch Med Wochenschr; 1987 Jun; 112(26):1032-7. PubMed ID: 3109868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal bowel permeability in ankylosing spondylitis and rheumatoid arthritis.
    Smith MD; Gibson RA; Brooks PM
    J Rheumatol; 1985 Apr; 12(2):299-305. PubMed ID: 4032403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal mucosal permeability in inflammatory rheumatic diseases. II. Role of disease.
    Mielants H; De Vos M; Goemaere S; Schelstraete K; Cuvelier C; Goethals K; Maertens M; Ackerman C; Veys EM
    J Rheumatol; 1991 Mar; 18(3):394-400. PubMed ID: 1906939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bowel permeability and CD45RO expression on circulating CD20+ B cells in patients with ankylosing spondylitis and their relatives.
    Vaile JH; Meddings JB; Yacyshyn BR; Russell AS; Maksymowych WP
    J Rheumatol; 1999 Jan; 26(1):128-35. PubMed ID: 9918253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Brief note on the use of cinmetacin in the treatment of rheumatic diseases].
    Viara M
    Clin Ter; 1977 Jun; 81(6):555-66. PubMed ID: 301808
    [No Abstract]   [Full Text] [Related]  

  • 7. Methodology issues in the evaluation of NSAID in inflammatory rheumatic diseases.
    Lequesne M
    J Rheumatol Suppl; 1990 Feb; 20():25-8. PubMed ID: 2182853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal mucosal permeability in inflammatory rheumatic diseases. I. Role of antiinflammatory drugs.
    Mielants H; Goemaere S; De Vos M; Schelstraete K; Goethals K; Maertens M; Ackerman C; Veys EM
    J Rheumatol; 1991 Mar; 18(3):389-93. PubMed ID: 1906938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hyperpermeability of the small intestine mucosa after prolonged application of non-steroidal anti-inflammatory drugs in patients with rheumatic diseases].
    Lebedeva VV; Gmoshinskiĭ IV; Mazo VK; Murav'ev IuV
    Eksp Klin Gastroenterol; 2008; (2):16-21. PubMed ID: 19148987
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of intestinal permeability in ankylosing spondylarthritis with a test using Cr-EDTA].
    Wendling D; Bidet A; Guidet M
    Rev Rhum Mal Osteoartic; 1990 Jan; 57(1):29-32. PubMed ID: 2108485
    [No Abstract]   [Full Text] [Related]  

  • 11. Review article: joint involvement in inflammatory bowel disease.
    De Vos M
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():36-42. PubMed ID: 15352892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six-month prospective study to monitor the treatment of rheumatic diseases with sustained-release flurbiprofen.
    Rovenský J; Miceková D
    Drugs Exp Clin Res; 2000; 26(1):19-24. PubMed ID: 10761533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of age and disease state in nonsteroidal antiinflammatory drug associated gastric bleeding.
    Llewellyn JG; Pritchard MH
    J Rheumatol; 1988 Apr; 15(4):691-4. PubMed ID: 3397979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-administration of the health food supplement, bovine colostrum, reduces the acute non-steroidal anti-inflammatory drug-induced increase in intestinal permeability.
    Playford RJ; MacDonald CE; Calnan DP; Floyd DN; Podas T; Johnson W; Wicks AC; Bashir O; Marchbank T
    Clin Sci (Lond); 2001 Jun; 100(6):627-33. PubMed ID: 11352778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on nonsteriodal anti-inflammatory drugs.
    Ardoin SP; Sundy JS
    Curr Opin Rheumatol; 2006 May; 18(3):221-6. PubMed ID: 16582683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ankylosing spondylitis and bowel disease.
    Rudwaleit M; Baeten D
    Best Pract Res Clin Rheumatol; 2006 Jun; 20(3):451-71. PubMed ID: 16777576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [NSAID prescription in patients with rheumatoid arthritis and cardiovascular disease].
    Pavlović R; Curković B; Babić-Naglić D; Kehler T
    Reumatizam; 2006; 53(1):22-4. PubMed ID: 17580545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal permeability is increased in a proportion of spouses of patients with Crohn's disease.
    Breslin NP; Nash C; Hilsden RJ; Hershfield NB; Price LM; Meddings JB; Sutherland LR
    Am J Gastroenterol; 2001 Oct; 96(10):2934-8. PubMed ID: 11693329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased intestinal permeability in ankylosing spondylitis--primary lesion or drug effect?
    Morris AJ; Howden CW; Robertson C; Duncan A; Torley H; Sturrock RD; Russell RI
    Gut; 1991 Dec; 32(12):1470-2. PubMed ID: 1773950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Compliance to therapy in daily practice--rheumatologic diseases].
    Gerster JC
    Schweiz Rundsch Med Prax; 1993 Nov; 82(48):1381-3. PubMed ID: 8296118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.